Omer Iqbal
机构: Professor of Opthalmology & Pathology, Loyola University Stritch School of Medicine.
主页: luc.edu
每年引用次数
引用次数
引用: 2,884
H-指数: 27
I10-指数 : 78
出版物: 569
Preclinical studies on a low molecular weight heparin
Jawed Fareed , Walter Jeske , Volker Eschenfelder , Orner Iqbal
Thrombosis Research 81 ( 2)
12
1996
PATHOGENESIS OF ATRIAL FIBRILLATION-POTENTIAL ROLE OF INFLAMMATORY RESPONSE.
Jawed Fareed , J Cunanan , F Baltasar , B Neville
The FASEB Journal 20 ( 4)
2006
Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
J Fareed , J Cunanan , M Demir , M Clarke
International Angiology 27 ( 3) 176 -192
13
2008
Coagulation laboratory testing in patients treated with argatroban.
S Ahmad , J M Walenga , M Bakhos , O Iqbal
Seminars in Thrombosis and Hemostasis 25 ( 2) 61 -64
68
1999
Dosage optimization of antithrombin drugs using ecarin clotting time in patients with heparin-induced thrombocytopenia undergoing off-pump coronary artery revascularization and percutaneous coronary interventions
O Iqbal
The Journal of Clinical Pharmacology 40 ( 9) 1064
2
2000
Hyperhomocysteinemia in Cancer Patients with Thrombosis is Not Associated With Methylene Tetrahydrofolate Reductase Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
Debra Hoppensteadt , S Deitcher , J Cunanan , M Demir
The FASEB Journal
2006
A Perspective on Low Molecular Weight Heparins in the Management of Thrombosis
Debra Hoppensteadt , Jeanine Walenga , A Ahsan , O Iqbal
Hamostaseologie 13
5
1993
Makeeva O
HE Abboud , E Abrahams , E Amsallem , C Aquilante
Comparative studies on the biochemical and pharmacological properties of a major metabolite of argatroban (M1): potential clinical implications
A Ahsan , S Ahmad , O Iqbal , R Schwarz
THROMBOSIS AND HAEMOSTASIS PS370 -PS370
10
1997
Clinical pharmacokinetic and pharmacodynamic studies on argatroban to optimize the anticoagulant dosage in interventional cardiovascular procedures
BE Lewis , O Iqbal , D Hoppensteadt , A Ahsan
THROMBOSIS AND HAEMOSTASIS P2010 -P2010
7
1997
Heparinase is capable of neutralizing the anticoagulant and hemorrhagic effects of a synthetic pentasaccharide
O Iqbal , H Shadid , P Silver , JM Walenga
Blood 96 ( 11) 52a -52a
6
2000
Anticoagulant dosage optimization of argatroban in a porcine model of cardiopulmonary bypass surgery.
S Ahmad , L Rusterholtz , S Jain , O Iqbal
Blood 98 ( 11) 47A -47A
5
2001
Prolonged argatroban treatment does not result in the generation of neutralizing antibodies
JM Walenga , S Ahmad , DA Hoppensteadt , O Iqbal
THROMBOSIS AND HAEMOSTASIS 390 -390
5
1999
Dosage adjustment of argatroban justified in combination with glycoprotein IIb/IIIa receptor antagonist: Laboratory and clinical implications
O Iqbal , BE Lewis , S Ahmad , DA Hoppensteadt
Blood 98 ( 11 Part 1)
4
2001
Heparinase is capable of neutralizing anticoagulant and anti-Xa effects of synthetic heparinominetic (pentasaccharide): potential clinical application
O Iqbal , P Silver , JM Walenga , S Ahmad
Blood 94 ( suppl 1) 234a -234a
2
1999
Specific quantitation of thrombin inhibitors using Ecarin clotting time: Application in point of care testing
O Iqbal , S Ahmad , DA Hoppensteadt , BE Lewis
CLINICAL CHEMISTRY 44 A50 -A51
2
1998
Monitoring of the anticoagulant effects of argatroban in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary interventions-The ARG 310 study.
O Iqbal , S Ahmad , BE Lewis , Y Mousa
CLINICAL CHEMISTRY 47 ( 6) A169 -A169
1
2001
Pharmacokinetics and pharmacodynamics of a synthetic antithrombin agent, argatroban, in man as studied by HPLC and functional methods: Implications in the monitoring and dosage-optimizations in cardiovascular patients.
S Ahmad , A Ahsan , O Iqbal , DA Hoppensteadt
FASEB JOURNAL 12 ( 4) A408 -A408
1
1998
Anticoagulant and antithrombotic effects of a synthetic factor Xa inhibitor (DX-9065a)
D Fareed , D Wyma , S Ahmad , O Iqbal
THROMBOSIS AND HAEMOSTASIS P1196 -P1196
1
1997
Direct thrombin inhibitor argatroban is capable of generating nitric oxide: Hematopharmacologic implications.
S Ahmad , O Iqbal , DA Hoppensteadt , D Fareed
BLOOD 102 ( 11) 78B -78B
2003